{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry Salicylate Reagent",
        "Advia Chemistry Salicylate"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K093939",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKJ"
    ],
    "Summary Letter Date": "May 14, 2010",
    "Summary Letter Received Date": "May 17, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3830"
    ],
    "Regulation Name(s)": [
        "Salicylate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Salicylate"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA 1650 Chemistry systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Chemistry Salicylate Reagent for quantitative determination of salicylate in human serum and plasma using ADVIA 1650 Chemistry systems",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of salicylate in human serum and plasma (lithium heparin) to aid in diagnosis of salicylate toxicity and overdose",
    "fda_folder": "Toxicology"
}